Embryo Project Encyclopedia Articles

“Program of Action of the International Conference on Population and Development” comprises the majority of context within the twenty-year sustainable development plan, International Conference on Population and Development Program of Action, hereafter POA, published in 1994 by the United Nations Population Fund or UNFPA. Given the rising global population, the goal of the POA was to outline the steps governments around the world were to take to achieve sustainable development by 2014. Under leadership of the United Nations Population Fund, 179 countries met in Cairo, Egypt, to debate the best way to address the growing global population and the need for sustainable development. The debates began on 5 September 1994 and ended on 13 September 1994, resulting in all 179 participating countries endorsing the Program of Action. The Program of Action encouraged participating countries to prioritize human rights, reproductive rights, and women’s empowerment during all future sustainable development plans and programs.

In 2005, the organization Asian Communities for Reproductive Justice, or ACRJ, published “A New Vision for Advancing Our Movement for Reproductive Health, Reproductive Rights, and Reproductive Justice,” hereafter “A New Vision,” in which the authors explain how reproductive justice is hindered by societal oppressions against women of color. ACRJ, known as Forward Together since 2012, was a founding member of SisterSong Women of Color Reproductive Justice Collective, a collective of organizations founded by people of color that work to advance the reproductive justice movement. In “A New Vision,” the authors elaborate that reproductive justice is about changing the societal structures that produce reproductive oppressions. They assert that a radical transformation is necessary in order to progress toward the establishment of full and equal human rights, reproductive rights, and economic rights to ensure equitable access to healthcare, education, and opportunity.

The HeLa cell line was the first immortal human cell line that George Otto Gey, Margaret Gey, and Mary Kucibek first isolated from Henrietta Lacks and developed at The Johns Hopkins Hospital in Baltimore, Maryland, in 1951. An immortal human cell line is a cluster of cells that continuously multiply on their own outside of the human from which they originated. Scientists use immortal human cell lines in their research to investigate how cells function in humans. Though the HeLa cell line has contributed to many advancements in biomedical research since the twentieth century, its usage in medical research has been controversial because Lacks did not consent to having her cells used for such purposes. As of 2020, scientists continue to use the HeLa cell line for numerous scientific advancements, such as the development of vaccines and the identification of many underlying disease mechanisms.